Minerva Surgical, Inc. (UTRS) |
|
0.2101 -0.016 (-6.91%)
|
03-24 15:59 |
|
Open: |
0.21 |
Pre. Close: |
0.2257 |
|
High:
|
0.2199 |
Low:
|
0.2 |
|
Volume:
|
137,547 |
Market Cap:
|
37(M) |
|
|
|
Technical analysis |
as of: 2023-03-24 4:30:59 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 0.41  One year: 0.52 |
| Support: |
Support1: 0.2 Support2: 0.16 |
| Resistance: |
Resistance1: 0.35 Resistance2: 0.44 |
| Pivot: |
0.24 |
| Moving Average: |
MA(5): 0.22 MA(20): 0.26
MA(100): 0.27 MA(250): 1.4 |
| MACD: |
MACD(12,26): -0.1 Signal(9): -0.1 |
| Stochastic oscillator: |
%K(14,3): 11.3 %D(3): 16.4 |
| RSI: |
RSI(14): 36.2 |
| 52-week: |
High: 4.65 Low: 0.15 |
| Average Vol(K): |
3-Month: 1,853 (K) 10-Days: 212 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ UTRS ] has closed above bottom band by 13.4%. Bollinger Bands are 38.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.22 - 0.22 |
0.22 - 0.22 |
|
Low:
|
0.2 - 0.2 |
0.2 - 0.2 |
|
Close:
|
0.21 - 0.21 |
0.21 - 0.21 |
|
Company Description |
|
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California. |
Headline News |
Fri, 24 Mar 2023
Minerva Surgical, Inc. (NASDAQ:UTRS) Q4 2022 Earnings Call Transcript - Yahoo Finance
Tue, 21 Mar 2023
Minerva Surgical (UTRS) Appoints Kaile Zagger as Chief ... - StreetInsider.com
Thu, 09 Feb 2023
Minerva Surgical closes $30M financing, has new controlling ... - Mass Device
Thu, 09 Feb 2023
Minerva Surgical Closes $30 Million Private Placement of Common ... - GlobeNewswire
Thu, 26 Jan 2023
Minerva Surgical (UTRS) Stock Surged 68.4% on Investor Interest - AskTraders
Wed, 28 Dec 2022
Minerva Surgical Announces Retirement of CEO David Clapper and ... - GlobeNewswire
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Health Information Services |
| Shares Out. |
30 (M) |
| Shares Float |
10 (M) |
|
% Held by Insiders
|
6.2 (%) |
|
% Held by Institutions
|
70.1 (%) |
|
Shares Short
|
448 (K) |
|
Shares Short P.Month
|
211 (K) |
Stock Financials |
|
EPS
|
-20.73 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
-78.55 |
|
Profit Margin (%)
|
-34.1 |
|
Operating Margin (%)
|
-73.5 |
|
Return on Assets (ttm)
|
-27.9 |
|
Return on Equity (ttm)
|
0 |
|
Qtrly Rev. Growth
|
0.6 |
|
Gross Profit (p.s.)
|
1.01 |
|
Sales Per Share
|
1.66 |
|
EBITDA (p.s.)
|
-0.87 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-31 (M) |
|
Levered Free Cash Flow
|
-39 (M) |
Stock Valuations |
|
PE Ratio
|
-0.02 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
-0.01 |
|
Price to Sales
|
0.12 |
|
Price to Cash Flow
|
-0.21 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
